Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)

.


from α1 via xlomafota.13 on Inoreader http://ift.tt/2tx5XIZ
via IFTTT